Vanda Pharmaceuticals
VNDA
£3.50
Share price
-0.43%
Change (1 day)
-25.02%
Change (1 year)
Categories
Vanda Pharmaceuticals (VNDA) - Net assets
Net assets on the balance sheet as of March 2025 : £0.38 Billion
According to Vanda Pharmaceuticals's latest financial reports the company has £0.38 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Vanda Pharmaceuticals - Net assets on balance sheet (from 2005 to 2025)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-12-31 | $£0.42 B | 0.34% |
| 2023-12-31 | $£0.42 B | -1.85% |
| 2022-12-31 | $£0.43 B | 16.5% |
| 2021-12-31 | $£0.37 B | 12.49% |
| 2020-12-31 | $£0.33 B | 6.11% |
| 2019-12-31 | $£0.31 B | 44.43% |
| 2018-12-31 | $£0.21 B | 123.19% |
| 2017-12-31 | $£97.21 M | -8.66% |
| 2016-12-31 | $£0.10 B | 18.57% |
| 2015-12-31 | $£89.76 M | -13.09% |
| 2014-12-31 | $£0.10 B | 286.15% |
| 2013-12-31 | $£26.74 M | 336.5% |
| 2012-12-31 | $£6.12 M | -71.54% |
| 2011-12-31 | $£21.53 M | -11.89% |
| 2010-12-31 | $£24.44 M | 71.73% |
| 2009-12-31 | $£14.23 M | -54.67% |
| 2008-12-31 | $£31.4 M | -25.5% |
| 2007-12-31 | $£42.14 M | 208.54% |
| 2006-12-31 | $£13.66 M | -23.18% |
| 2005-12-31 | $£17.78 M | 114.12% |
| 2004-12-31 | $£8.3 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | £28.79 B | 7,418.72% | 🇨🇭 Switzerland |
 Eli Lilly LLY | £11.86 B | 2,998.61% | 🇺🇸 USA |
 Johnson & Johnson JNJ | £58.48 B | 15,173.06% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | £13.06 B | 3,311.70% | 🇺🇸 USA |
 Pfizer PFE | £67.86 B | 17,622.72% | 🇺🇸 USA |
 Titan Pharmaceuticals
TTNP | £1.4 M | -99.63% | 🇺🇸 USA |
 Merck MRK | £36.24 B | 9,363.90% | 🇺🇸 USA |